AACR Project GENIE: Powering Precision Medicine through an International Consortium
Tóm tắt
The AACR Project GENIE is an international data-sharing consortium focused on generating an evidence base for precision cancer medicine by integrating clinical-grade cancer genomic data with clinical outcome data for tens of thousands of cancer patients treated at multiple institutions worldwide. In conjunction with the first public data release from approximately 19,000 samples, we describe the goals, structure, and data standards of the consortium and report conclusions from high-level analysis of the initial phase of genomic data. We also provide examples of the clinical utility of GENIE data, such as an estimate of clinical actionability across multiple cancer types (>30%) and prediction of accrual rates to the NCI-MATCH trial that accurately reflect recently reported actual match rates. The GENIE database is expected to grow to >100,000 samples within 5 years and should serve as a powerful tool for precision cancer medicine.
Significance: The AACR Project GENIE aims to catalyze sharing of integrated genomic and clinical datasets across multiple institutions worldwide, and thereby enable precision cancer medicine research, including the identification of novel therapeutic targets, design of biomarker-driven clinical trials, and identification of genomic determinants of response to therapy. Cancer Discov; 7(8); 818–31. ©2017 AACR.
See related commentary by Litchfield et al., p. 796.
This article is highlighted in the In This Issue feature, p. 783
Từ khóa
Tài liệu tham khảo
Grossman, 2016, Toward a shared vision for cancer genomic data, N Engl J Med, 375, 1109, 10.1056/NEJMp1607591
Tannock, 2016, Limits to personalized cancer medicine, N Engl J Med, 375, 1289, 10.1056/NEJMsb1607705
Joyner, 2016, What happens when underperforming big ideas in research become entrenched?, JAMA, 316, 1355, 10.1001/jama.2016.11076
Shrager, 2014, Rapid learning for precision oncology, Nat Rev Clin Oncol, 11, 109, 10.1038/nrclinonc.2013.244
Obermeyer, 2016, Predicting the future — big data, machine learning, and clinical medicine, N Engl J Med, 375, 1216, 10.1056/NEJMp1606181
Siu, 2016, Facilitating a culture of responsible and effective sharing of cancer genome data, Nat Med, 22, 464, 10.1038/nm.4089
Blue Ribbon, 2016, Panel report to the National Cancer Advisory Board [Internet]
AACR Project GENIE Publicly Releases Large Cancer Genomic Data Set [Internet]
International Cancer Genome Consortium, 2010, International network of cancer genome projects, Nature, 464, 993, 10.1038/nature08987
Derry, 2012, Developing predictive molecular maps of human disease through community-based modeling, Nat Genet, 44, 127, 10.1038/ng.1089
Gao, 2013, Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal, Sci Signal, 6, l1, 10.1126/scisignal.2004088
Cerami, 2012, The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data, Cancer Discov, 2, 401, 10.1158/2159-8290.CD-12-0095
Jones, 2015, Personalized genomic analyses for cancer mutation discovery and interpretation, Sci Transl Med, 7, 283ra53, 10.1126/scitranslmed.aaa7161
OncoTree [Internet]
Lawrence, 2014, Discovery and saturation analysis of cancer genes across 21 tumour types, Nature, 505, 495, 10.1038/nature12912
Miao, 2016, Genomic determinants of cancer immunotherapy, Curr Opin Immunol, 41, 32, 10.1016/j.coi.2016.05.010
Campbell, 2016, Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas, Nat Genet, 48, 607, 10.1038/ng.3564
Cancer Genome Atlas Network, 2012, Comprehensive molecular characterization of human colon and rectal cancer, Nature, 487, 330, 10.1038/nature11252
Cancer Genome Atlas Network, 2012, Comprehensive molecular portraits of human breast tumours, Nature, 490, 61, 10.1038/nature11412
Forbes, 2015, COSMIC: exploring the world's knowledge of somatic mutations in human cancer, Nucleic Acids Res, 43, D805, 10.1093/nar/gku1075
Chang, 2016, Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity, Nat Biotechnol, 34, 155, 10.1038/nbt.3391
Chakravarty, OncoKB: a precision oncology knowledge base, JCO PO 2017 May 16 [Epub ahead of print]
Conley, 2016, Abstract IA38: NCI MATCH: a national precision medicine trial – Conception, development, and adjustment, Cancer Epidemiol Biomarkers Prev, IA38
Gracia, 2007, The learning healthcare system: workshop summary, 2013
Tunis, 2009, The national oncologic PET registry: lessons learned for coverage with evidence development, J Am Coll Radiol, 6, 360, 10.1016/j.jacr.2009.01.016